1993 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 1993: 35 approvals, 0 patent expiries, 0 Phase 3 milestones.

FDA / EMA / MHRA approvals (35)

• 1993-04-12 — Claritin · Generic (originally Schering-Plough) · United States · Hematology
• 1993-12-28 — Effexor · Generic (originally Wyeth/Pfizer) · United States · Neuroscience
• 1993-12-29 — Risperdal · Johnson & Johnson (Janssen) · United States · Neuroscience
• 1993-12-30 — Neurontin · Generic (originally Parke-Davis/Pfizer) · United States · Neuroscience
• 1994 — Glustat · Metabolic
• 1994 — Serzone · Bristol-Myers Squibb · Neuroscience
• 1994 — Luvox · Neuroscience
• 1994 — Elspar · Merck & Co. · Oncology
• 1994 — TECHNETIUM BICISATE
• 1994 — Prograf · Astellas Pharma · Immunology
• 1994 — SALMETEROL XINAFOATE
• 1994 — Pulmicort Respules · AstraZeneca K.K. · Immunology
• 1994 — Fragmin · Pfizer · Cardiovascular
• 1994 — Semprex-D · Auxilium Pharms Inc · Infectious Disease
• 1994 — MOFEZOLAC · Pain
• 1994 — PEGASPARGASE
• 1994 — FLUDEOXYGLUCOSE F 18
• 1994 — PHENIRAMINE MALEATE
• 1994 — (+)-Ketoprofen · Immunology
• 1994 — CYSTEAMINE BITARTRATE
• 1994 — Famvir · Novartis · Immunology
• 1994 — Cerezyme · Sanofi · Cardiovascular
• 1994 — Cystagon · Mylan · Metabolic
• 1994 — Zemuron · Fresenius Kabi · Neuroscience
• 1994 — Renormax · Cardiovascular
• 1994 — Navelbine · Pierre Fabre · Oncology
• 1994 — DORZOLAMIDE HYDROCHLORIDE
• 1994 — Rocuronium · Merck & Co. · Neuroscience
• 1994 — IOBENGUANE
• 1994 — SALMETEROL
• 1994 — ROCURONIUM BROMIDE
• 1994 — INDIUM PENTETREOTIDE
• 1994 — TACROLIMUS ANHYDROUS
• 1994 — DEXIBUPROFEN · Immunology
• 1994 — Trusopt · Merck & Co. · Cardiovascular

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.